-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On December 1st the European Commission released the World Top 2500 R-D Investors 2016.the list shows the total research and development spending of 2,500 companies worldwide in the 2015-2016 fiscal year, including 590 in the European Union, 837 in the United States, 356 in Japan, 327 in China, 111 in Taiwan, 75 in South Korea and 58 in Switzerland. The world's top 100 research and development enterprises accounted for 53.1% of the total 2500 enterprises in research and development. Among them, Investment by Chinese companies jumped 24.7% year-on-year, with the largest growth sectors being ICT (information, communications and technology), health and automotive.investment in industrial research and development reached 666 billion euros, with industries such as software, IT, pharmaceuticals and automotive promoting investment and sales in research and development. However, total global sales fell by 3.6 per cent, mainly due to the performance of low-tech sectors, particularly oil and mining, which are cheap commodities.data shows that EU companies invested EUR 188.3 billion in research and development in the 2015/2016 financial year, an annual growth rate of 7.5 per cent, which puts EU companies ahead of global trends (6.6 per cent) and the US (5.9 per cent).
30 EU companies are among the world's top 100 research and development investors, mainly in the automotive, pharmaceutical and biotechnology, ICT, aerospace and defense sectors. The largest investors are in Germany (68.8 billion euros), France (28.5 billion euros), the United Kingdom (28.2 billion euros) and the Netherlands (14.1 billion euros).asia's research and development grew fastest, particularly in China (up 24.7 per cent to 49.8 billion euros), although sales also fell. Globally, the software industry had the highest year-over-year growth in research and development, at 12.3 per cent, followed by pharmaceuticals (9.8 per cent), IT hardware (7.6 per cent) and automobiles (6.7 per cent).
the EU Industrial Research and Development Investment Scoreboard is accompanied by a survey of 1,000 top R and D investors in the EU. This suggests that investment in research and development in the automotive and parts sectors (-0.8 per cent) is expected to decline in the coming years, while investment in high-tech, particularly in healthcare, pharmaceuticals and technology hardware, is expected to grow by 7 to 8 per cent.huawei's investment has been increasing year by year to lead Chinese manufacturers. As a leader among telecoms equipment makers, Huawei's investment in research and development among Chinese manufacturers is fiercest. This year's investment in research and development reached 8.35 billion euros (about 60.6 billion yuan), ranking eighth in the world, and its investment in research and development has surpassed Toyota's.
eu industrial research and development investment scoreboard is published annually by the European Commission (DG Research and Innovation and Joint Research Centre) to collect the company's main research and development and economic indicators. The 2016 edition reviewed the performance of the world's top 2,500 research and development investment companies, accounting for about 90% of total corporate-funded research and development. It also includes the focus of the EU's top 1000 research and development investors. The scoreboard is accompanied by the 2016 EU Industrial Research and Development Investment Trends Survey.